Furthermore, their results also provided functional evidence concerning the possible role of miR-222 in ovarian cancer, as it was demonstrated that miR-222 upregulation is able to induce an enhancement of ovarian cancer cell proliferation potential, possibly by downregulating its target, P27Kip1. Here, CDKN1B is linked to ovarian cancer.